The Muscular Dystrophy Association recently granted the NIH’s Bryan Traynor $400,000 to sequence the genomes of 1,000 sporadic ALS cases. The goal of the one year project is to identify novel ALS-linked genes. In July 2012 Biogen Idec announced they are collaborating with Duke University and the HudsonAlpha Institute for Biotechnology to sequence the genomes of 1,000 ALS patients over the course of five years. Hopefully, these two projects will yield important findings that help us to better understand the causes of ALS at the genetic level, and even provide insights towards identifying potential new ALS therapies.
Copyright © 1996–2018 Biomedical Research Forum, LLC. All Rights Reserved.Share this: